chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received concerning a 9 year old white male with no medical history and no drug allergies who on 29-JUN-2003 was vaccinated with a single subcutaneous dose of varicella virus vaccine live (Oka/Merck) ("Lot #1423F") in the left arm. Illness at the time of vaccination included a fever and sore throat. On 19-JUN-2007, the patient developed breakthrough chicken pox rash with 75 lesions (pox) on the face, trunk and back. The patient also had a low grade fever. On 18-JUN-2007 a quick test streptococcus was done with negative results. Subsequently, the patient recovered on 26-JUN-2007. Unspecified medical attention was sought. No product quality complaint was involved. Follow-up information received from the physician regarding laboratory results: Throat culture plate performed on 20-Jun-2007 - negative, Rapid Strep performed on 18-Jun-2007 - negative. Additional information is not expected.
She had first dose of Moderna COVID-19 vaccine on 9/3/2019 after consulting with PCP.  Within 1 hour she started to feel fatigue, achy, and short of breath and voice change, with chest pain and palpitations.   She had some facial flushing, but no hives or itching and no swelling of the mouth or throat, or difficulty swallowing.  She has had some nausea with pain but no vomiting.    She has been taking tylenol and half dose Xanax, last dose this AM, but she has not been using any Benadryl    She still feels midline chest pain which radiates to the back, and is still feeling lightheaded and short of breath, and when she called her PCP and was told to come to the ED for evaluation.
muscle pain, lightheadedness (comes and goes), nauseau (off and on), headache, right sinus/ ear pain, insomnia, faint chest pain, numbness right arm and leg, diarrhea, wheezing (off and on), fatigue.
pt recv vax 12JAN98 & 19JAN98 pt exp varicella like rash;
PT REPORTED FEELING ANXIUS AND DIZZY, ALSO REPORTS BLURRY VISOIN PT REPORTS FEELING BETTER AFTER ABOUT 5 MIN, HR 80, 96% O2, PT REPORTS SMILAR REACTION TO PREVIOUS VACCIN DID NOT TASKE ANY MEDICATION TODAY PT WAS ENCOURAGE TO LIE FLAT AND TO HYDRATE PT LEFT SITE WITH PARENT AFTER 15 MIN WAS RESOLVED SYMPTOMS
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 72-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), in Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 71 years for Covid-19 immunisation; CoviD-19 vaccine (COVID-19 VACCINE), as dose 3 (booster), single (Batch/Lot number: unknown) for Covid-19 immunisation; CoviD-19 vaccine mRNA (mRNA 1273) (COVID-19 VACCINE MODERNA), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for Covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications received within 2 weeks. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "recovering" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2022) Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of drug ineffective, Covid-19 included Anti-viral medication from 15Jul2022 to 19Jul2022. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Received the flu vaccination on 10/18/18 at 1315 and pt developed hives, itching, swelling of eye, redness to chest.
Numb  and tingly left arm and left leg for 8 hours. No medical treatment was sought.
Patient with complaints of redness and lump starting two days after vaccine. Now seven days out and lump and redness persist, and now having itchiness and site is warm to the touch.
local rxn: red, raised area where inj was given, warm to touch;tx DPH, cold packs, rxn to MMR;
On 8/17/2022, she was having a terrible headache. She was in bed for 3 days. She called her doctor on the telephone and he gave her a PAXLOVID prescription. She had a horrible taste in her mouth the whole time she took the PAXLOVID. She did not have a fever, but had a congestion, and a general debilitating feeling. She took a COVID-19 home test on 8/17/2022 and the results were definitely positive, a pitch-black bar. Her symptoms resolved by 9/7/2022.
Chills, nausea, dizziness, redness and swelling at site of injection.
(1) High fever 103.6 x 10 days (on 2 off) (2) Loss of appetite (3) Diarrhea (4) Rashes all over the body
p/vax pt exp chills, throat swelling which defined & being unable to swallow;watery eyes & later that noc, emesis;resolved during noc;no tx;
Gave first dose of Moderna (COVID) 6month-5year and gave 0.3mL instead of 0.25mL. Spoke with Dr. regarding the issue, had me report to VAERS. Called and spoke with mom about the situation as well. No symptoms currently and acting normal. Informed mom to report back to the office if noticing or experiencing any symptoms/concerns. ER if symptomatic with SOB, lethargy and or any life threatening issues.
red arm at injection site that started 8 days after injection. no pain.  just started, 8 days after vaccine
THURSDAY 10/10 CLIENT NOTED UPSET STOMACH, ON FRIDAY HE NOTED BODY ACHES AND THAT NIGHT HIS RIGHT ARM HURT.  ON SATURDAY, REDNESS TO RIGHT ARM WITH VOMITING AND A FEVER AND HEADACHE.  SYMTPOMS CONTINUED ON SUNDAY WITH REDNESS INCREASING TO RIGHT ARM.  CLIENT INTO CLINIC TO SEE PCP FOR REACTION.  HE STATES HE STILL HAD FEVER LAST NIGHT, RIGHT ARM VERY TENDER, RED, AND WARM.  HE IS NAUSEATED BUT HAS NOT THROWN UP TODAY.
The morning after I received the Moderna vaccine I saw a bruise on my right rib cage. The shot was given on my left arm.
Tinnitus continuous sound - Since date of 3rd of 4 Covid shots on 4-7-2022.
30 mins post vaccination, client complained of new onset tickling in throat, voice hoarseness then cough. Client awake and alert. Vital signs stable, BP slightly elevated 164/71 @ 1226, O2 sats 98%. Blood glucose 154. Per staff protocol, Benadryl discussed but doctor declined to order administration. Daughter is driving her home.
Severe reaction to the first shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Severe reaction to the first shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Severe reaction to the first shot). At the time of the report, VACCINATION COMPLICATION (Severe reaction to the first shot) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Followup received on 25 May 2021 contains non-significant information.
Urticaria and intense pruritus appears spontaneously in randomly patches across the body, often affecting large areas to a moderate degree, but exhibiting sever dermatographic characteristics, responding quickly to scratching with raised, blister-like reactions. The condition is chronic but shifts in and out in intensity and location, and significantly impairs sleep. Treatment with topical steroid cream is moderately successful, as is treatment with oral antihistamine. In the 6 days since appearing, this condition has neither improved nor deteriorated further.
1st dose Oct2019, 2nd 11Oct2022; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 61-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 0.5 ml of 1st dose intramuscularly in October 2019).   On 11th October 2022, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. On 11th October 2022, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.   Additional Information: GSK receipt date: 11-Oct-2022 Reporter's comment: The pharmacist  gave consent to follow-up by GlaxoSmithKline. Additional supportive information: The patient received 2nd dose of Shingrix later than the recommended interval, which led to lengthening of vaccine schedule.
Had flu vaccine. Experienced pain around injection site in upper left shoulder. I was warned that there would be residual soreness so I was not alarmed about the pain until it never went away and felt deep in the shoulder. Pain has continued in upper left shoulder for several months and I have limited range of motion. Particularly difficult to move arm across chest or lift it above 90 degrees. Have had 3+ doctors' appointments to try to resolve the problem. Currently taking Norco, ibuprofen and starting physical therapy. Doctors believe it could be subacromial bursitis or adhesive capsulitis. Have not had any MRI or x-rays.
16JAN h/a, myalgias, sweating, nausea, vomiting 17JAN99-21JAN99;
Vax admin in am 5Nov, Tylenol given q4h, no problems intially, 2 wks later found pt blue & not breathing- when picked up started to breathing, then had seizure-had some problem breathing-went to Hosp ER, admit,tests done, all neg. MD rec DT
I'm very tired I have to make myself get out of bed, sleeping a lot, and the roof of my mouth is raw
Arm reddened and warm to touch, approximately 3 inches in diameter, around injection site. Referred to private MD. Saw MD given several allergic medication antibiotic. Mother states was told it just a local reaction.
Skin rednesses/inflamation/flushing that started in hands and since initial and second covid vaccination has spread to arms, legs, torso and face resulting in FATIGUE and MUSCLE WEAKNESS. Eye and nasal irritation along with rash arounf lips. Tingling and numbess in feet and ankles. Weight loss
The shot was given at the top of my arm. The following morning I could not move my arm without extreme pain. I called the pharmacy and was told I could take MOTRIN and use ice. It didn't get better, so I saw my dr on 11-13-14. He prescribed prednisone 20 mg. One tablet 2x dat for 5 days.
Mom states that since pt last vaccine administration, pt has been less verbal, sits up less steadily, no longer rolls from belly to back (will roll from back to belly) and she does not hold eye contact as long as she did before.
Large ulcers/sores under tongue with fever/fatigue 4+ days after vaccination; had typical post vaccine symptoms 24-48 hours after injection that resolved.
pt recvd vax & 4hrs p/shot pt began vomit;bottle feedings-vomited p/APAP/Motrin given very fussy devel red warm, swollen area @ site of inj;woke up w/fine red rash;
HEART PAIN; RANDOM ERRATIC HEARTBEATS; EPISODES OF FEELING FAINT; WRECK; SCARED; HIVES EVERYWHERE; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's past medical history included: covid-19. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 08-OCT-2021 for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On OCT-2021, the patient experienced heart pain. On OCT-2021, the patient experienced random erratic heartbeats. On OCT-2021, the patient experienced episodes of feeling faint. On OCT-2021, the patient experienced wreck. On OCT-2021, the patient experienced scared. On OCT-2021, the patient experienced hives everywhere. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the hives everywhere, heart pain, random erratic heartbeats, episodes of feeling faint, wreck and scared was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure as the case assessed as non-serious
Patient received vaccine on 1/15/2022 with a BUD date of 1/9/2022. No adverse event. Offered to be revaccinated per guidelines.
not much soreness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 29Jan2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Latex allergy" (unspecified if ongoing), notes: The first vaccine I didn't have any real side effects; I have a latex allergy. The patient's concomitant medications were not reported. The following information was reported: PAIN (non-serious), outcome "unknown", described as "not much soreness".  Additional information: age 53 (units not provided) as reported.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Covid arm developed 8 days after injection - 2 red circles one the size of a half dollar and the other a quarter - they also itched initially and are rough/raised but not huge
lethargic; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (lethargic) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LETHARGY (lethargic). At the time of the report, LETHARGY (lethargic) outcome was unknown.            Concomitant medications includes birth control pills. No treatment medication were reported.  Patient states the first dose of the Moderna Covid-19 Vaccine was administered on Feb2021, and the second dose 4 weeks later.   This case was linked to MOD-2022-459618, MOD-2022-459640 (Patient Link).
patient complained of shortness of breath ,nausea and pain in chest .  benadrly  was given and ems called
tingling w/numbness of both hands-nails on finger red-23hr admit-solumedrol & DPH;
Diarrhea; Gas in Stomach; Bloating; Stomach pain; This spontaneous case was reported by a consumer and describes the occurrence of FLATULENCE (Gas in Stomach), ABDOMINAL DISTENSION (Bloating), ABDOMINAL PAIN UPPER (Stomach pain) and DIARRHOEA (Diarrhea) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced FLATULENCE (Gas in Stomach), ABDOMINAL DISTENSION (Bloating) and ABDOMINAL PAIN UPPER (Stomach pain). On an unknown date, the patient experienced DIARRHOEA (Diarrhea). The patient was treated with CALCIUM CARBONATE for Adverse event, at a dose of UNK dosage form. At the time of the report, FLATULENCE (Gas in Stomach), ABDOMINAL DISTENSION (Bloating), ABDOMINAL PAIN UPPER (Stomach pain) and DIARRHOEA (Diarrhea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. Other treatment included peppermint water.
4 undetectable titers were determined p/completion of vax series 1 yr ago;
Information has been received from a consumer concerning her daughter, a 13 year old female patient with no pertinent medical history and drug reactions/allergies who 02-AUG-2009 was vaccinated with the first dose of GARDASIL (lot number, route and site not reported). There was no concomitant medication. On 02-AUG-2009, after receiving GARDASIL, the patient has been experiencing nausea, diarrhea, vomiting and pelvic pain. The consumer reported that the diarrhea, nausea and vomiting were on and off, but the pelvic pain was still on going. The patient had sought unspecified medical attention. Several tests including blood work, urinalysis and pelvic ultrasound have been done, but the results did not come back. At the time of the report, the patient did not recover. Additional information has been requested.
From ED note: Patient is a 19 yrear old female with h/o POTS, migraines w/aura, asthma, and endometriosis who presented for evaluation of syncopy. She reports she feels lightheaded and nauseaous in the settong her POTS disease, but was feeling worse yesterday 9/19/2023 and this moring.  Patient then recieved her influenza vaccine at 1600 and felt worsening lightheadedness and nausea. Has significant phobia of needles.  Patient reported a spinning senation and distoreted hearing, sat down and then had a syncopal episode, not breathing and had a weak pulse.   syncopal event requiring CPR. Campus response was called, caregiver was transported to PCH ED. Required oxygen via NC.  Witnesses did not report patient hitting her head.  Has had syncopal episodes before, but has never stopped breathing or required chest compressions 9/19 had migraine and nausea, 9/20 was feeling a little nauseous before shot. 9/21 stayed home from school today.
Lot of pressure in head like someone has hands on head and crushing head. Headache that won't go away.  Goes from mild to moderate.  No over counter medicine has helped. Chest pains/ pressure.
Dose 1 given 1/29/2021 Moderna lot # 010M20A  Patient died of Covid 19, respiratory failure
This spontaneous prospective pregnancy report as received from a nurse refers to a 22-year-old, female patient with scoliosis and abnormal Papanicolaou smear (PAP). The patient had no relevant medical history or products taken prior to or during her pregnancy. She had not been pregnant before. On 08-NOV-2016, the patient was vaccinated with a dose of GARDASIL 9 injection (intramuscularly in her right deltoid; lot # M028323, expiration date: 26-SEP-2018). On an unknown date, the patient became pregnant (confirmed by an urine pregnancy test performed on 09-SEP-2017) with last menstrual period (LMP) of 15-OCT-2016 and Estimated Date of Delivery (EDD) of 22-JUL-2017 (calculated based on LMP). The pregnancy outcome was unknown at the time of the report (the outcome was pending). Additional information has been requested.
mom states that a "few days after the flu vaccines he started having a compulsion to roll up  the pant legs on his trousers." This never happened before.
A week after receiving the second does of the COVID vaccine the patient began having fevers and then developed swelling of the wrists joints. Also contributes left sided neck , left wrist , and right thigh pain. Wrists had decreased range of motion. Developed bilateral eye redness. Naproxen, Tylenol , and Motrin given for symptoms.
Initial report received from a pharmacist on 30 October 2013. A 30-year-old female patient, whose age, concomitant medications were not reported, had received a dose of FLUZONE HD (Lot number UT4721BA, intradermal at left deltoid on 30 October 2013). On 30 October 2013, 10 minutes after receiving vaccine the patient experienced numbness of fingers of left hand and then numbness extended to left hand and left arm. Patient was allergic to nickel. At the time of this report the outcome of adverse events was not recovered. Documents held by sender: none.
Narrative: Mortality Review - exact cause of death not indicated, vaccine given less than 30 days prior to death
Suspected vaccination failure; Brain fog due to flu; Brain fog; This case was reported by a consumer via other manufacturer and described the occurrence of suspected vaccination failure in a 30-year-old female patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced vaccination failure (serious criteria GSK medically significant), influenza and foggy feeling in head. On an unknown date, the outcome of the vaccination failure, influenza and foggy feeling in head were unknown.   It was unknown if the reporter considered the vaccination failure, influenza and foggy feeling in head to be related to Influenza vaccine Quadrivalent unspecified season.  Additional details were provided as follows: The age at vaccination was not reported. The patient experienced brain fog due to flu. This case was considered as suspected vaccination failure as time to onset, laboratory confirmation test were unknown at the time of reporting.
Patient developed sore throat, itchy and watery eyes, coughing within ~ 2 hours of vaccine injection. Patient also reports chills and difficulty breathing and (had to use inhaler).
This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS, DECREASED APPETITE, TASTE DISORDER, SUSPECTED COVID-19, and VACCINATION SITE INFLAMMATION in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 051F21A, 023M20A, and 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced ILLNESS, DECREASED APPETITE, TASTE DISORDER, SUSPECTED COVID-19, VACCINATION SITE INFLAMMATION, VACCINATION SITE SWELLING, VACCINATION SITE PAIN, HEADACHE, PYREXIA, NAUSEA, VOMITING, and FATIGUE. At the time of the report, ILLNESS, DECREASED APPETITE, TASTE DISORDER, SUSPECTED COVID-19, HEADACHE, PYREXIA, NAUSEA, VOMITING, and FATIGUE outcome was unknown and VACCINATION SITE INFLAMMATION, VACCINATION SITE SWELLING, and VACCINATION SITE PAIN had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available) on an unknown date, Body temperature 101F (High).         No concomitant medication was provided. No treatment medication was provided.  Based on the current available information and temporal association between the use of the product, and the start date of the events, a causal relationship cannot be excluded.   This case was linked to MOD-2021-370018 (Patient Link).
pt was given vax & lt clinic go outside & felt faint returned inside & fell struck head on counter cut lip & chin;
Information has been received from a physician concerning a 10 year old male with a history of hepatitis A, who on 22-JUL-2009 was vaccinated with his 2nd dose of VARIVAX (Merck) (lot # 664506/0688Y), 0.5ml. Concomitant therapy included VAQTA (MSD). On 22-JUL-2009 the patient experienced itching and swelling at the injection site. There were no labs and diagnostic tests performed. The patient had sought unspecified medical attention. At the time of the report, the patient's status was unknown. Follow up information has been received indicating that they cannot find the patient's chart because they do not know the patient's name. No further information is available.
After vaccination, patient was instructed to sit in the waiting area for 15 minutes. Patient states that they experienced feeling flushed, chills, dry, scratchy throat feeling. Observation personnel noticed a minor rash on neck. Patient was evaluated by provider.